NCT02247648

Efficacy of Extended-release, Once Daily Tramadol for Post Operative Analgesia in Shoulder Arthroscopy

Efficacy of Extended-release, Once Daily Tramadol for Post Operative in Ambulatory Shoulder Arthroscopy

• Status: Terminated
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Accepted

Summary

The investigators hypothesize that the use of tramadol will reduce pain and analgesic consumption after arthroscopic shoulder surgery.

Detailed description

The purpose of the study was to evaluate the efficacy of tramadol long acting for post operative pain in patients who had an arthroscopic shoulder surgery in ambulatory setting in comparison with a placebo. The intensity of pain was evaluated on a visual analog scale as the quantity of hydromorphone taken by patients, and the side effects during the first 72 hours.

Conditions

• Pain
• Vertigo
• Nausea
• Pruritus

Interventions

Type	Name	Description
DRUG	tramadol	Patients from tramadol group received tramadol 100 mg day one, 100 mg day 2, and 200 mg day 3
DRUG	Placebo	Patients from control group received a "shame" tramadol pill on day one, two, and 3

Timeline

• Start date: 2013-06-01
• Primary completion: 2017-12-01
• Completion: 2017-12-01
• First posted: 2014-09-25
• Last updated: 2020-07-24

Locations

1 site across 1 country: Canada